Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesIs the current concept of recurrent ovarian carcinoma as a chronic disease also applicable in platinum resistant patients
Archives of Gynecology and Obstetrics, 07/01/09
Guth U et al. - There is not only the known dichotomy between platinum sensitive and resistant ROC patients, but rather also within the platinum resistant subgroup itself. There is a considerably large subgroup of platinum resistant patients who will subsequently enter a phase where multiple treatment programs will be considered and administered. These patients have similar survival rates compared to those from the platinum sensitive patient group and the therapy principles of a chronic disease are applicable.
Related Articles
Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
BMC Cancer, 10/21/09
Relevance Score: 69%
Serous papillary peritoneal carcinoma: Unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review
Critical Reviews in Oncology/Hematology, 11/12/09
Relevance Score: 67%
Precursors of endometrial and ovarian carcinoma
Virchows Archiv, 11/02/09
Relevance Score: 67%
Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology
Diagnostic Cytopathology, 10/28/09
Relevance Score: 67%
XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma
European Journal of Obstetrics & Gynecology and Reproductive Biology, 10/09/09
Relevance Score: 67%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Emerging role of pemetrexed in ovarian cancer
Expert Review of Anticancer Therapy, 12/04/09
Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis
Journal of Bone and Mineral Metabolism, 12/03/09
Endometrial Cancer in Postmenopausal Women Using Estradiol-Progestin Therapy
Obstetrics and Gynecology, 12/01/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Endometriosis: associations with menopause, hormone replacement therapy and cancer
Menopause International, 12/06/09
Emerging role of pemetrexed in ovarian cancer
Expert Review of Anticancer Therapy, 12/04/09
Vaginal Schwannoma in a case with uterine myoma
Annals of Diagnostic Pathology, 12/04/09
Sponsor
Article Search
Sponsor